Inhibitors of TonB function identified by a high-throughput screen for inhibitors of iron acquisition in uropathogenic Escherichia coli CFT073

mBio

Volumn 5, Issue 2, 2014, Pages

  Yep, Alejandra ^a   McQuade, Thomas ^b   Kirchhoff, Paul ^b   Larsen, Martha ^b   Mobley, Harry L T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PROTEIN TONB;

ARTICLE; BACTERIOPHAGE; BACTERIOSTASIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; GROWTH INHIBITION; HIGH THROUGHPUT SCREENING; IRON TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTON MOTIVE FORCE; UROPATHOGENIC ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; COLIPHAGES; DRUG EVALUATION, PRECLINICAL; ESCHERICHIA COLI PROTEINS; IRON; MEMBRANE PROTEINS; UROPATHOGENIC ESCHERICHIA COLI; VIRUS ATTACHMENT;

EID: 84899769431     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01089-13     Document Type: Article

References (39)

1. Sanchez GV, Master RN, Karlowsky JA, Bordon JM. 2012. In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrob. Agents Chemother. 56: 2181-2183. http://dx.doi.org/10.1128/AAC.06060-11.
2. Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, Marchese A. 2009. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int. J. Antimicrob. Agents 34:407-413. http://dx.doi.org/10.1016/ j.ijantimicag.2009.04.012.
3. Anderson GJ, Vulpe CD. 2009. Mammalian iron transport. Cell. Mol. Life Sci. 66:3241-3261. http://dx.doi.org/10.1007/s00018-009-0051-1.
4. Masson PL, Heremans JF, Schonne E. 1969. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 130:643-658. http:// dx.doi.org/10.1084/jem.130.3.643.
5. Hagan EC, Mobley HL. 2009. Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol. Microbiol. 71:79-91. http://dx.doi.org/10.1111/j.1365-2958.2008.06509.x.
6. Wiener MC. 2005. TonB-dependent outer membrane transport: going for Baroque? Curr. Opin. Struct. Biol. 15:394-400. http://dx.doi.org/ 10.1016/j.sbi.2005.07.001.
7. Schauer K, Rodionov DA, de Reuse H. 2008. New substrates for TonBdependent transport: do we only see the "tip of the iceberg"? Trends Biochem. Sci. 33:330-338. http://dx.doi.org/10.1016/j.tibs.2008.04.012.
8. Krewulak KD, Vogel HJ. 2011. TonB or not TonB: is that the question? Biochem. Cell Biol. 89:87-97. http://dx.doi.org/10.1139/O10-141.
9. Larsen RA, Letain TE, Postle K. 2003. In vivo evidence of TonB shuttling between the cytoplasmic and outer membrane in Escherichia coli. Mol. Microbiol. 49:211-218. http://dx.doi.org/10.1046/j.1365-2958.2003.03579.x.
10. Gresock MG, Savenkova MI, Larsen RA, Ollis AA, Postle K. 2011. Death of the TonB shuttle hypothesis. Front. Microbiol. 2:00206. http:// dx.doi.org/10.3389/fmicb.2011.00206.
11. Cascales E, Lloubès R, Sturgis JN. 2001. The TolQ-TolR proteins energize TolA and share homologies with the flagellar motor proteins MotAMotB. Mol. Microbiol. 42:795-807. http://dx.doi.org/10.1046/j.1365-2958.2001.02673.x.
12. De Mot R, Vanderleyden J. 1994. The C-terminal sequence conservation between OmpA-related outer membrane proteins and MotB suggests a common function in both gram-positive and gram-negative bacteria, possibly in the interaction of these domains with peptidoglycan. Mol. Microbiol. 12:333-334. http://dx.doi.org/10.1111/j.1365-2958.1994.tb01021.x.
13. Peacock R, Weljie AM, Peter Howard S, Price FD, Vogel HJ. 2005. The solution structure of the C-terminal domain of TonB and interaction studies with TonB box peptides. J. Mol. Biol. 345:1185-1197. http:// dx.doi.org/10.1016/j.jmb.2004.11.026.
14. Gumbart J, Wiener MC, Tajkhorshid E. 2007. Mechanics of force propagation in TonB-dependent outer membrane transport. Biophys. J. 93: 496-504. http://dx.doi.org/10.1529/biophysj.107.104158.
15. Carter DM, Miousse IR, Gagnon JN, Martinez E, Clements A, Lee J, Hancock MA, Gagnon H, Pawelek PD, Coulton JW. 2006. Interactions between TonB from Escherichia coli and the periplasmic protein FhuD. J. Biol. Chem. 281:35413-35424. http://dx.doi.org/10.1074/ jbc.M607611200.
16. James KJ, Hancock MA, Gagnon JN, Coulton JW. 2009. TonB interacts with BtuF, the Escherichia coli periplasmic binding protein for cyanocobalamin. Biochemistry 48:9212-9220. http://dx.doi.org/10.1021/ bi900722p.
17. Cassat JE, Skaar EP. 2013. Iron in infection and immunity. Cell Host Microb. 13:509-519. http://dx.doi.org/10.1016/j.chom.2013.04.010.
18. Brock JH, Licéaga J, Kontoghiorghes GJ. 1988. The effect of synthetic iron chelators on bacterial growth in human serum. FEMS Microbiol. Immunol. 1:55-60.
19. Foley TL, Simeonov A. 2012. Targeting iron assimilation to develop new antibacterials. Expert Opin. Drug Discov. 7:831-847. http://dx.doi.org/ 10.1517/17460441.2012.708335.
20. Torres AG, Redford P, Welch RA, Payne SM. 2001. TonB-dependent systems of uropathogenic Escherichia coli: aerobactin and heme transport and TonB are required for virulence in the mouse. Infect. Immun. 69: 6179-6185. http://dx.doi.org/10.1128/IAI.69.10.6179-6185.2001.
21. Carpenter BM, Whitmire JM, Merrell DS. 2009. This is not your mother's repressor: the complex role of Fur in pathogenesis. Infect. Immun. 77:2590-2601. http://dx.doi.org/10.1128/IAI.00116-09.
22. Routh MD, Zalucki Y, Su CC, Zhang Q, Shafer WM, Yu EW. 2011. Efflux pumps of the resistance-nodulation-division family: a perspective of their structure, function, and regulation in gram-negative bacteria. Adv. Enzymol. Relat. Areas Mol. Biol. 77:109-146. http://dx.doi.org/ 10.1002/9780470920541.ch3.
23. Schwyn B, Neilands JB. 1987. Universal chemical assay for the detection and determination of siderophores. Anal. Biochem. 160:47-56. http:// dx.doi.org/10.1016/0003-2697(87)90612-9.
24. Litwin MS, Saigal CS. 2007. Urologic diseases in America. NIH Publication 07-5512:3-7. NIH, Bethesda, MD.
25. Andrews SC, Robinson AK, Rodríguez-Quiñones F. 2003. Bacterial iron homeostasis. FEMS Microbiol. Rev. 27:215-237. http://dx.doi.org/ 10.1016/S0168-6445(03)00055-X.
26. Hagan EC, Lloyd AL, Rasko DA, Faerber GJ, Mobley HL. 2010. Escherichia coli global gene expression in urine from women with urinary tract infection. PLOS Pathog. 6:e1001187. http://dx.doi.org/10.1371/ journal.ppat.1001187.
27. Snyder JA, Haugen BJ, Buckles EL, Lockatell CV, Johnson DE, Donnenberg MS, Welch RA, Mobley HL. 2004. Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect. Immun. 72: 6373-6381. http://dx.doi.org/10.1128/IAI.72.11.6373-6381.2004.
28. Kammler M, Schön C, Hantke K. 1993. Characterization of the ferrous iron uptake system of Escherichia coli. J. Bacteriol. 175:6212-6219.
29. Lau CK, Ishida H, Liu Z, Vogel HJ. 2013. Solution structure of Escherichia coli FeoA and its potential role in bacterial ferrous iron transport. J. Bacteriol. 195:46-55. http://dx.doi.org/10.1128/JB.01121-12.
30. Kehres DG, Janakiraman A, Slauch JM, Maguire ME. 2002. SitABCD is the alkaline Mn(2) transporter of Salmonella enterica serovar Typhimurium. J. Bacteriol. 184:3159-3166. http://dx.doi.org/10.1128/ JB.184.12.3159-3166.2002.
31. Sabri M, Léveillé S, Dozois CM. 2006. A SitABCD homologue from an avian pathogenic Escherichia coli strain mediates transport of iron and manganese and resistance to hydrogen peroxide. Microbiology 152: 745-758. http://dx.doi.org/10.1099/mic.0.28682-0.
32. Caza M, Lépine F, Dozois CM. 2011. Secretion, but not overall synthesis, of catecholate siderophores contributes to virulence of extraintestinal pathogenic Escherichia coli. Mol. Microbiol. 80:266-282. http:// dx.doi.org/10.1111/j.1365-2958.2011.07570.x.
33. Achard ME, Chen KW, Sweet MJ, Watts RE, Schroder K, Schembri MA, McEwan AG. 2013. An antioxidant role for catecholate siderophores in Salmonella. Biochem. J. 454:28. http://dx.doi.org/10.1042/BJ20121771.
34. Stojiljkovic I, Kumar V, Srinivasan N. 1999. Non-iron metalloporphyrins: potent antibacterial compounds that exploit haem/Hb uptake systems of pathogenic bacteria. Mol. Microbiol. 31: 429-442. http://dx.doi.org/10.1046/j.1365-2958.1999.01175.x.
35. Hom K, Heinzl GA, Eakanunkul S, Lopes PE, Xue F, MacKerell AD, Wilks A. 2013. Small molecule antivirulents targeting the iron-regulated heme oxygenase (HemO) of P. aeruginosa. J. Med. Chem. 56:2097-2109. http://dx.doi.org/10.1021/jm301819k.
36. Walsh C. 2003. Antibiotics: actions, origins, resistance. ASM Press, Washington, DC.
37. Mobley HL, Green DM, Trifillis AL, Johnson DE, Chippendale GR, Lockatell CV, Jones BD, Warren JW. 1990. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect. Immun. 58:1281-1289.
38. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
39. Zhang JH, Chung TD, Oldenburg KR. 1999. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4:67-73. http://dx.doi.org/10.1177/ 108705719900400206.